News
Unveiling 4 Analyst Insights On TScan Therapeutics
23 Apr 24
Analyst Ratings
Wedbush Reiterates Outperform on TScan Therapeutics, Maintains $10 Price Target
23 Apr 24
News, Price Target, Reiteration, Analyst Ratings
TScan Therapeutics Prices Upsized $150M Public Offering 2,472,581 Common Shares At $7.13/Share
17 Apr 24
News
TScan Therapeutics Reports Launch Of $125M Proposed Public Offering
16 Apr 24
News, Offerings
TScan Therapeutics Provides Update On Its Solid Tumor And Heme Malignancies Clinical Programs
16 Apr 24
News
Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday
22 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Barclays Maintains Overweight on TScan Therapeutics, Raises Price Target to $9
7 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on TScan Therapeutics, Maintains $15 Price Target
7 Mar 24
News, Price Target, Reiteration, Analyst Ratings
TScan Therapeutics: Q4 Earnings Insights
6 Mar 24
Earnings
Wedbush Reiterates Outperform on TScan Therapeutics, Maintains $9 Price Target
1 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Press releases
TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
22 Apr 24
News, Press Releases
TScan Therapeutics Announces Closing of Upsized Public Offering
19 Apr 24
Press Releases
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
17 Apr 24
Press Releases
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
16 Apr 24
News, Financing, Press Releases
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
16 Apr 24
Health Care, Press Releases
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
2 Apr 24
News, Press Releases
TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
28 Feb 24
Press Releases
TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR
14 Feb 24
News, Press Releases
TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development
6 Feb 24
News, Management, Press Releases